INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 22 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $0 | -100.0% | 146 | -99.2% | 0.00% | – |
| Q4 2019 | $11,000 | +22.2% | 19,275 | +124.1% | 0.00% | – |
| Q3 2019 | $9,000 | -75.7% | 8,600 | -73.1% | 0.00% | – |
| Q2 2019 | $37,000 | -49.3% | 31,962 | -14.7% | 0.00% | – |
| Q1 2019 | $73,000 | -9.9% | 37,479 | +5.9% | 0.00% | – |
| Q4 2018 | $81,000 | -61.4% | 35,391 | +15.0% | 0.00% | – |
| Q3 2018 | $210,000 | -61.7% | 30,774 | +32.2% | 0.00% | – |
| Q2 2018 | $549,000 | – | 23,283 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |